StockMarketWire.com - Clinical stage biotechnology company ValiRx said discussions for the intention to form the joint venture with Alpha Blue Ocean had not progressed.

The potential venture would now be 'considered along with other opportunities,' the company said.

The talks were first announced by ValiRX back in May.


At 8:32am: [LON:VAL] ValiRx PLC share price was -0.04p at 0.15p



Story provided by StockMarketWire.com